Quadrant Capital Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,737
| Closed | -$651K | – | 2574 |
|
|
2019
Q3 | $651K | Buy |
6,737
+147
| +2% | +$14K | 0.1% | 164 |
|
|
2019
Q2 | $592K | Buy |
6,590
+404
| +7% | +$38.4K | 0.09% | 184 |
|
|
2019
Q1 | $570K | Buy |
6,186
+2,572
| +71% | +$225K | 0.1% | 171 |
|
|
2018
Q4 | $222K | Sell |
3,614
-428
| -11% | -$31.6K | 0.06% | 312 |
|
|
2018
Q3 | $348K | Buy |
4,042
+206
| +5% | +$18.2K | 0.1% | 143 |
|
|
2018
Q2 | $289K | Buy |
3,836
+527
| +16% | +$43.8K | 0.1% | 165 |
|
|
2018
Q1 | $288K | Sell |
3,309
-620
| -16% | -$59.5K | 0.1% | 166 |
|
|
2017
Q4 | $397K | Sell |
3,929
-214
| -5% | -$24.1K | 0.16% | 120 |
|
|
2017
Q3 | $588K | Buy |
4,143
+72
| +2% | +$9.81K | 0.24% | 81 |
|
|
2017
Q2 | $476K | Sell |
4,071
-2
| -0% | -$245 | 0.21% | 93 |
|
|
2017
Q1 | $492K | Buy |
4,073
+34
| +0.8% | +$4.07K | 0.22% | 94 |
|
|
2016
Q4 | $455K | Sell |
4,039
-42
| -1% | -$4.68K | 0.23% | 81 |
|
|
2016
Q3 | $417K | Buy |
4,081
+468
| +13% | +$50.6K | 0.27% | 67 |
|
|
2016
Q2 | $346K | Hold |
3,613
| – | – | 0.24% | 76 |
|
|
2016
Q1 | $357K | Sell |
3,613
-101
| -3% | -$10.4K | 0.23% | 77 |
|
|
2015
Q4 | $438K | Sell |
3,714
-651
| -15% | -$75.3K | 0.3% | 73 |
|
|
2015
Q3 | $468K | Sell |
4,365
-251
| -5% | -$31.1K | 0.32% | 61 |
|
|
2015
Q2 | $529K | Buy |
+4,616
| New | +$528K | 0.34% | 59 |
|
Other funds holding CELG
Quadrant Capital Group's CELG Position: Q4 2019 in Review
Quadrant Capital Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,737 shares — an estimated $651K sold.
Quadrant Capital Group first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $651K in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Quadrant Capital Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Quadrant Capital Group sold 6,737 Celgene Corp shares in Q4 2019, an estimated $651K.
- Quadrant Capital Group first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
- Quadrant Capital Group's Celgene Corp position peaked at $651K in Q3 2019.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Quadrant Capital Group's 13F filing for Q4 2019, filed 3 Feb 2020.